Phillips-Medisize wins new supply contract for Sanofi injection pen components
By Phillips-Medisize
Phillips-Medisize Corp has signed a supply agreement for insulin pen components with Sanofi, a leader for diabetes treatment. As a result, injection pen component production at the plant in Kontiolahti, Finland, has been expanded with an automated production line.